RECRUITING

NMT for Parkinson's Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Parkinson's Disease (PD) is defined by characteristic motor symptoms including slow movements, small movements, difficulty with movement initiation and disruptions in timing. Besides gross motor symptoms, fine motor impairments in PD cause difficulties with everyday tasks such as writing, self-care, and fine object manipulation. These activity limitations can lead to disability, social isolation, and a reduced quality of life. In a series of breakthrough studies Michael Thaut and colleagues developed Neurologic Music Therapy (NMT) and found it can address many gross motor impairments and improve gait and balance. Other music therapies such as Music-supported Therapy (MST) have proven motor benefits in stroke patients through movement exercises with musical instruments. However, the pathological basal ganglia (BG) in PD brains leads to a reduced supply of those internally generated movements. In contrast, externally cued movements (eg. via a beat or a rhythm) during NMT sessions are instantaneously entrained to the period of a rhythmic stimulus possibly without involvement of the BG. The underlying idea is that rhythm is the essential component relating music specifically to motor behavior. The mechanism of action is called "rhythmic entrainment" where one system's motion or signal frequency entrains the frequency of another system. The effect of NMT on fine motor function has not been investigated yet. Music activities are important in the lives of many older adults. Notably, the use of music has been associated with increased well-being for older adults, as it fosters social connection and mood regulation. Furthermore, many musical activities have limited physical demands, making them attainable for individuals who are living with mobility impairments or other physical restrictions. Based on the literature and the investigators preliminary studies, the investigators propose to test the efficacy of Neurologic Music Therapy in comparison to Music Supported Therapy and Occupational Therapy (OT) as standard of care on adults in the Parkinson's spectrum. The investigators have defined a working plan using different musical instruments and growing tempo to specifically improve fine motor movements.

Official Title

Neurologic Music Therapy for Enhancing Fine Motor Control in Parkinson's Disease

Quick Facts

Study Start:2017-04-26
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03049033

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 45 to 85
  2. * Diagnosis of Parkinson's Disease using the UK Brain Bank Criteria
  3. * Fine motor impairments (if available, scores 2 and higher on the UPDRS motor examination part III.23 and 24)
  4. * Medication stable for at least 30 days.
  1. * Features suggestive of other causes of parkinsonism, including cerebrovascular disease or history of major head trauma
  2. * Inability to move fingers or hands
  3. * Hoehn and Yahr stage 4 and higher
  4. * Ferrous metal implants which may interfere with the MEG data acquisition and/or be an MRI safety concern
  5. * Dementia
  6. * Participants engaged in other research studies involving music therapies
  7. * Participants whose insurance does not cover Occupational Therapy costs or who have no insurance.

Contacts and Locations

Study Contact

Lucas Lattanzio, BA
CONTACT
303.724.2205
Lucas.Lattanzio@CUAnschutz.edu
Isabelle Buard, PhD
CONTACT
303.724.5973
Isabelle.Buard@CUAnschutz.edu

Principal Investigator

Isabelle Buard, PhD
PRINCIPAL_INVESTIGATOR
University of Colorado, Denver

Study Locations (Sites)

University of Colorado Denver
Aurora, Colorado, 80045
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Isabelle Buard, PhD, PRINCIPAL_INVESTIGATOR, University of Colorado, Denver

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-04-26
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2017-04-26
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Parkinson Disease